Oruka Therapeutics ORKA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$32.96M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 39.3% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 12.54% to 9.76% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +1,091,222 | 15.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,010,018 | 2.3% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +412,218 | 3.1% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +283,309 | 3.9% |
| Capital Research | Mutual Fund | 2026/Q3 | +3,401,639 | 5.1% |
| FMR | Mutual Fund | 2026/Q3 | +1,626,242 | 13.7% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +1,554,597 | 2.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,463,094 | 7.5% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +1,363,744 | 2.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,214,897 | 2.9% |
| Bellevue Asset Management AG | Mutual Fund | 2026/Q3 | +1,150,182 | 2.4% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +1,080,882 | 4.6% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +1,068,087 | 1.6% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,059,629 | 4.0% |
| Summit Partners Public Asset Management, LLC | Hedge Fund | 2026/Q3 | +658,301 | 1.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | Kristine Ball | Independent Director | Derivative Exercise and Sale | -18,000 | $106.99 | – |
| 11 Nov 2026 | Arjun Agarwal | Senior VP of Finance & Treasurer | Derivative Exercise and Sale | -10,000 | $107.00 | 14,219 |
| 1 Nov 2026 | Lawrence Klein | Chief Executive Officer | Derivative Exercise and Sale | -25,000 | $98.40 | 923,128 |
| 19 Oct 2026 | Paul Quinlan | General Counsel | Derivative Exercise and Sale | -9,000 | $79.49 | 29,995 |
| 14 Oct 2026 | Joana Goncalves | Chief Medical Officer | Derivative Exercise and Sale | -7,000 | $77.71 | 31,771 |
| 11 Oct 2026 | Arjun Agarwal | Senior VP of Finance & Treasurer | Derivative Exercise and Sale | -9,999 | $82.84 | 14,219 |
| 30 Sep 2026 | Lawrence Klein | Chief Executive Officer | Derivative Exercise and Sale | -25,000 | $84.78 | 923,128 |
| 20 Sep 2026 | Paul Quinlan | General Counsel | Derivative Exercise and Sale | -10,000 | $95.31 | 29,995 |
| 20 Sep 2026 | Arjun Agarwal | Senior VP of Finance & Treasurer | Automatic Disposition | -533 | $95.75 | 14,219 |
| 14 Sep 2026 | Paul Quinlan | General Counsel | Open Market Disposition | -1,039 | $95.71 | 29,995 |
| 14 Sep 2026 | Joana Goncalves | Chief Medical Officer | Open Market Disposition | -947 | $95.71 | 31,771 |
| 14 Sep 2026 | Joana Goncalves | Chief Medical Officer | Derivative Exercise and Sale | -7,000 | $94.22 | 31,771 |
| 14 Sep 2026 | Lawrence Klein | Chief Executive Officer | Open Market Disposition | -2,452 | $95.71 | 923,128 |
| 14 Sep 2026 | Arjun Agarwal | Senior VP of Finance & Treasurer | Open Market Disposition | -560 | $95.71 | 14,752 |
| 14 Sep 2026 | Laura Sandler | Chief Operating Officer | Open Market Disposition | -906 | $95.71 | 235,478 |
| 10 Sep 2026 | Arjun Agarwal | Senior VP of Finance & Treasurer | Derivative Exercise and Sale | -9,459 | $94.02 | 14,752 |
| 31 Aug 2026 | Lawrence Klein | Chief Executive Officer | Derivative Exercise and Sale | -75,000 | $92.44 | 925,580 |
| 31 Aug 2026 | Laura Sandler | Chief Operating Officer | Derivative Exercise and Sale | -5,000 | $92.01 | 236,384 |
| 23 Aug 2026 | Larry Edwards | Chief Commercial Officer | Other Acquisition | +100,000 | – | 100,000 |
| 23 Aug 2026 | Larry Edwards | Chief Commercial Officer | Other Derivative Acquisition | +20,000 | $102.42 | 20,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 6,464,212 | 9.8% | 7.1 |
| 15 Oct 2026 | 6,112,214 | 9.2% | 7.3 |
| 30 Sep 2026 | 7,778,131 | 11.7% | 6.3 |
| 15 Sep 2026 | 7,623,327 | 11.5% | 11.6 |
| 31 Aug 2026 | 7,793,678 | 11.8% | 9.3 |
| 14 Aug 2026 | 8,303,245 | 12.5% | 11.3 |
No comments yet — be the first to weigh in on ORKA.
Sign in to join the discussion.